Multisystem inflammatory syndrome in adults after acute coronavirus disease 2019 in a Japanese woman: A case report

Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfu...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Kyohei, Koizumi, Yusuke, Tamura, Shinobu, Nakashima, Tsuyoshi, Kobai, Kaori, Tanaka, Rikako, Shibata, Mami, Shima, Nozomu, Nemoto, Shigeki, Fukumoto, Nobu, Kato, Seiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486615/
https://www.ncbi.nlm.nih.gov/pubmed/34620535
http://dx.doi.org/10.1016/j.jiac.2021.09.014
Descripción
Sumario:Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.

Ejemplares similares